PMS Tracker: August Funds Slump – Valcreate & Ambit Impact
- Several portfolio management service (PMS) funds experienced sharp declines in August 2024, with Valcreate Investment Managers' Lifesciences and Specialty opportunities strategy suffering the steepest losses.
- Data from PMS Bazaar reveals substantial losses across several PMS funds during August 2024.
- Several factors likely contributed to the August 2024 downturn in PMS funds.
“`html
PMS Funds Experience Significant Declines in August 2024
Table of Contents
Several portfolio management service (PMS) funds experienced sharp declines in August 2024, with Valcreate Investment Managers’ Lifesciences and Specialty opportunities strategy suffering the steepest losses. This downturn reflects broader market volatility and sector-specific challenges.
Last updated: 2025/09/11 15:01:23
August 2024 PMS Performance: Key Declines
Data from PMS Bazaar reveals substantial losses across several PMS funds during August 2024. Valcreate investment Managers’ Lifesciences and Specialty Opportunities strategy led the decline, dropping 10.19%.Other notable underperformers included funds focused on microcaps and small/midcap stocks.
| Fund Manager | Strategy | Decline (%) |
|---|---|---|
| Valcreate Investment Managers | Lifesciences and Specialty Opportunities | 10.19 |
| Ambit Investment Advisors | Micro Marvels Portfolio | ~9.00 |
| Money Grow Asset | Small Midcap Strategy | ~9.00 |
| Accelt Asset | Long Term Equity Fund | 8.51 |
| Anand Rathi | Impress PMS | 8.28 |
| Waya Financial Technologies | Bin73 Sunrise Alpha | 8.24 |
| Avestha Fund | Long Term Growth strategy | 8.06 |
| Amaltas Asset | Keystone Fund | 7.31 |
| Square 64 Capital | Multicap Strategy | 7.26 |
| Motilal Oswal AMC | India Growth Strategy | 6.88 |
| Money Grow asset | Blend | 6.85 |
| Bonanza Portfolio | Multicap | 6.58 |
| Valcreate Investment Managers | Growing India Strategy | 6.49 |
Source: Livemint
Factors Contributing to the Decline
Several factors likely contributed to the August 2024 downturn in PMS funds. These include:
- Market Volatility: Global economic uncertainty and geopolitical tensions created a volatile market surroundings.
- Sector-Specific Challenges: The Lifesciences and Specialty Opportunities strategy’s significant decline suggests potential headwinds within those sectors.
- Small and Midcap Underperformance: Funds focused on small and midcap companies generally underperformed larger-cap stocks during this period.
- Profit Booking: Some investors may have taken profits after a period of strong gains in the